2 news items
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
LLY
29 May 24
children and adolescents. Childhood NCDs can have substantial, lifelong implications for children and their families, including disabilities, chronic
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
LLY
21 May 24
bowel disease associated with progressive bowel damage, disability and decreased health-related quality of life. If not adequately controlled, it may
- Prev
- 1
- Next